Intellectual Property India Publishes Patent Application for 'Low Sodium Oxybate Once Nightly Composition' Filed by Tris Pharma, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517080344 A) filed by Tris Pharma, Inc., Monmouth junction, U.S.A., on Aug. 25, for 'low sodium oxybate once nightly composition.'

Inventor(s) include Chavan Patil, Mahesh; Patel, Hiren; Patel, Devins; Liang, Alfred; and Jain, Paras Rameshlal.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "Compositions providing a once-a-night dose of oxybate are provided. The compositions containing bilayer-coated oxybate anion exchange resin complex multiparticulates provide modified release of the oxybate for 5 to 8 hours post-dosing. Also provided are methods of treating patients in need thereof with pharmaceutical compositions containing the oxybate - anion exchange resin complex."

The patent application was internationally filed on Feb. 02, 2024, under International application No.PCT/US2024/014347.

Disclaimer: Curated by HT Syndication.